Laboratory of Metabolomics offers targeted and non-targeted metabolomics analysis using highly specialized instruments, including a combination of a liquid chromatograph with a mass spectrometer (with an accuracy of 0.0001 Da) and a 600 MHz NMR spectrometer.
Cell metabolism is an essential feature of life and results in the formation of metabolites in a living organism. Analysis of their concentration changes is one of the basic diagnostic tool of modern medicine. Laboratory of Metabolomics offers targeted and non-targeted metabolomics analysis using highly specialized instruments, including a mass spectrometer (with an accuracy of 0.0001 Da) and a 600 MHz NMR spectrometer. We focus mainly on metabolic analyses of low molecular weight substances in tissues, cell cultures and biological fluids (blood plasma, urine, cerebrospinal fluid, tissue extracts, cell media and lysates).
The lab is also equipped with an experimental 7 Tesla scanner based on magnetic resonance enabling non-invasive imaging (MRI) of biological systems but also other types of samples. Imaging sequences allow the monitoring of a wide range of in vivo, ex vivo and in vitro processes and are also suitable for functionalized therapy monitoring using magnetic nanoparticles (theranostics). In addition, using spectroscopic methods (MRS), we can monitor biochemical profiles of the examined tissues, including dynamic pharmacological and metabolic processes in vivo.
Watch a video tour of our Laboratory of Metabolomics.
Take a virtual tour of our modern Metabolomics Laboratory.
Projects
APVV project no. SK-AT-20-0010, “Multiparametric examinations of Miyoshi myopathy using magnetic resonance modalities.” (The Laboratory is a principal investigator, in cooperation with Medical University of Vienna;High-Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria)
VEGA project no. 1/0092/22, “Application of the above-standard radiological, proteomic, and genetic analyzes in the differential diagnostics of progressive forms of multiple sclerosis.” (The Laboratory is a principal investigator, in cooperation with UHM)
The most important publications
Strbak O, Balejcikova L, Kmetova M, Gombos J, Kovac J, Dobrota D, Kopcansky P. Longitudinal and transverse relaxivity analysis of native ferritin and magnetoferritin at 7 T MRI. International Journal of Molecular Sciences 2021, 22, 8487. doi:10.3390/ijms22168487
https://www.mdpi.com/1422-0067/22/16/8487
Baranovicova E, Kalenska D, Tomascova A, Holubcikova S, Lehotsky J. Time-related metabolomics study in the rat plasma after global cerebral ischemia and reperfusion: Effect of ischemic preconditioning. IUBMB Life 2020, 72:2010-2023. doi: 10.1002/iub.2340
https://iubmb.onlinelibrary.wiley.com/doi/epdf/10.1002/iub.2340
Hnilicova, P., Strbak, O., Kolisek, M., Kurca, E., Zelenak, K., Sivak, S., Kantorova, E. Current methods of magnetic resonance for noninvasive assessment of molecular aspects of pathoetiology in Muliple Sclerosis. Int J Mol Sci2020, 21:6117. doi: 10.3390/ijms21176117
https://www.mdpi.com/1422-0067/21/17/6117
Kovalska M, Hnilicova P, Kalenska D, Tomascova A, Adamkov M, Lehotsky J: Effect of Methionine Diet on Time-Related Metabolic and Histopathological Changes of Rat Hippocampus in the Model of Global Brain Ischemia. Biomolecules 2020, 10:1-20. doi: 10.3390/biom10081128
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465067/
Grayston A, Zhang YJ, Garcia-Gabilondo M, Arrue M, Martin A, Kopcansky P, Timko M, Kovac J, Strbak O, Castellote L, Belloli S, Moresco RM, Picchio M, Roig A, Rosell A. Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke. Journal of Cerebral Blood Flow and Metabolism 2021, 42, 237-252. doi:10.1177/0271678X211028816
Strbak O, Balejcikova L, Kmetova M, Gombos J, Trancikova A, Pokusa M, Kopcansky P. Quantification of iron release from native ferritin and magnetoferritin induced by vitamins B2 and C. Int J Mol Sci 2020, 21:6332. doi:10.3390/ijms21176332
https://www.mdpi.com/1422-0067/21/17/6332
Baranovicova E, Galanda T, Galanda M, Hatok J, Kolarovszki B, Richterova R, Racay P. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects – a preliminary study. IUBMB Life 2019, 71:1994-2002. doi: 10.1002/iub.2149
https://iubmb.onlinelibrary.wiley.com/doi/full/10.1002/iub.2149
Hnilicová,P., Bálentová, S., Kalenská, D., Muríň, P., Hajtmanová, E., Lehotský, J., Anatomic and metabolic alterations in the rodent frontal cortex caused by clinically relevant fractionated whole-brain irradiation. Neurochemistry International 2022, 154, 105293. doi: 10.1016/j.neuint.2022.105293
https://www.sciencedirect.com/science/article/pii/S0197018622000183?via%3Dihub
Baranovicova E, Kalenska D, Tomascova A, Lehotsky J. Metabolomic study of altered energy metabolism during global forebrain ischemia and ischemic precoditioning in blood plasma in homocysteine treated rats. J Physiol Pharmacol 2018, 69:901-909. doi: 10.26402/jpp.2018.6.04
http://www.jpp.krakow.pl/journal/archive/12_18/pdf/10.26402/jpp.2018.6.04.pdf
Heckova, E., Dal-Bianco, a., Strasser, B., Hangel, G.H., Lipka, L., Motyka, s., Hingerl, L., Rommer, P.S., Berger, T., Hnilicová, P., Kantorová, E., Leutmezer, F., Kurča, E., Gruber, S., Trattnig, S., Bogner, W., Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis. Radiology 2022, 303, 141-150. doi:10.1148/radiol.210614